AN2 Therapeutics, Inc. (ANTX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$38.11M | +32.9% |
| 2024 | -$56.79M | +18.4% |
| 2023 | -$69.64M | -64.8% |
| 2022 | -$42.26M | -95.9% |
| 2021 | -$21.57M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$38.11M | +32.9% |
| 2024 | -$56.79M | +18.4% |
| 2023 | -$69.64M | -64.8% |
| 2022 | -$42.26M | -95.9% |
| 2021 | -$21.57M | — |